214450 Stock Chart & Stats
$378000.00
-$6,500.00(-1.69%)
―
--
Day’s Range― - ―
52-Week Range$255,000.00 - $713,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₩3.52T
Enterprise Value$3.08M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)19.9
Beta0.14
Next Earnings
Aug 07, 2026EPS Estimate
4,043.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3733.32
Shares Outstanding10,389,648
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
214450 FAQ
What was PharmaResearch Co., Ltd.’s price range in the past 12 months?
PharmaResearch Co., Ltd. lowest stock price was $255000.00 and its highest was $713000.00 in the past 12 months.
What is PharmaResearch Co., Ltd.’s market cap?
PharmaResearch Co., Ltd.’s market cap is ₩3.52T.
When is PharmaResearch Co., Ltd.’s upcoming earnings report date?
PharmaResearch Co., Ltd.’s upcoming earnings report date is Aug 07, 2026 which is tomorrow.
How were PharmaResearch Co., Ltd.’s earnings last quarter?
PharmaResearch Co., Ltd. released its earnings results on May 08, 2026. The company reported $3733.32 earnings per share for the quarter, beating the consensus estimate of $3557.03 by $176.29.
Is PharmaResearch Co., Ltd. overvalued?
According to Wall Street analysts PharmaResearch Co., Ltd.’s price is currently Undervalued.
Does PharmaResearch Co., Ltd. pay dividends?
PharmaResearch Co., Ltd. does not currently pay dividends.
What is PharmaResearch Co., Ltd.’s EPS estimate?
PharmaResearch Co., Ltd.’s EPS estimate is 4,043.92.
How many shares outstanding does PharmaResearch Co., Ltd. have?
PharmaResearch Co., Ltd. has 10,389,648 shares outstanding.
What happened to PharmaResearch Co., Ltd.’s price movement after its last earnings report?
PharmaResearch Co., Ltd. reported an EPS of $3733.32 in its last earnings report, beating expectations of $3557.03. Following the earnings report the stock price went up 2.556%.
Which hedge fund is a major shareholder of PharmaResearch Co., Ltd.?
Currently, no hedge funds are holding shares in KR:214450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Celltrion Pharm Inc.
―
Mezzion Pharma Co., Ltd.
―
OliX Pharmaceuticals, Inc.
―
ABL Bio, Inc.
―
Kolon TissueGene. Inc. Shs Korean Deposit Receipt Repr 1/5 Sh
―